The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Advances in vaccine adjuvants
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Interferon-γ and B Cell Stimulatory Factor-1 Reciprocally Regulate Ig Isotype Production
Snapper, C. M., & Paul, W. E. (1987) · Science · doi:10.1126/science.3107127 · Cited by 1,920
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
Yang, R.-B., Mark, M. R., Gray, A., Huang, A., Xie, M. H., Zhang, M., Goddard, A., Wood, W. I., Gurney, A. L., & Godowski, P. J. (1998) · Nature · doi:10.1038/26239 · Cited by 1,205
Human TH1 and TH2 subsets: doubt no more
Romagnani, S. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90120-i · Cited by 1,089
Cherwinski, H. M., Schumacher, J. H., Brown, K. D., & Mosmann, T. R. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1229 · Cited by 1,036
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast
Valenzuela, P., Medina, A., Rutter, W. J., Ammerer, G., & Hall, B. D. (1982) · Nature · doi:10.1038/298347a0 · Cited by 877
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870
Biologically erodable microspheres as potential oral drug delivery systems
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., et al. (1997) · Nature · doi:10.1038/386410a0 · Cited by 823
Two types of mouse helper T-cell clone
Mosmann, T. R., & Coffman, R. L. (1987) · Immunology Today · doi:10.1016/0167-5699(87)90171-x · Cited by 801
Sparwasser, T., Koch, E.-S., Vabulas, R. M., Heeg, K., Lipford, G. B., Ellwart, J. W., & Wagner, H. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199806)28:06<2045::aid-immu2045>3.0.co;2-8 · Cited by 794
The role of IL-10 in crossregulation of TH1 and TH2 responses
Mosmann, T. R., & Moore, K. W. (1991) · Immunology Today · doi:10.1016/s0167-5699(05)80015-5 · Cited by 768
Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide
Kirschning, C. J., Wesche, H., Merrill Ayres, T., & Rothe, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2091 · Cited by 753
Oral tolerance: immune mechanisms and treatment of autoimmune diseases
Weiner, H. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01053-0 · Cited by 731
Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M., & Tice, T. R. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90133-e · Cited by 689
CpG islands as gene markers in the vertebrate nucleus
Bird, A. P. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90294-0 · Cited by 678
Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., & Krieg, A. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.870 · Cited by 677
(1992) · International Journal of Biochemistry · doi:10.1016/0020-711x(92)90281-5 · Cited by 671
Häcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G. B., & Wagner, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6230 · Cited by 653
Aluminum compounds as vaccine adjuvants
Gupta, R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00008-8 · Cited by 623
Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato
Tacket, C. O., Mason, H. S., Losonsky, G., Clements, J. D., Levine, M. M., & Arntzen, C. J. (1998) · Nature Medicine · doi:10.1038/nm0598-607 · Cited by 581
Jakob, T., Walker, P. S., Krieg, A. M., Udey, M. C., & Vogel, J. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3042 · Cited by 541
(1984) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/72.4.955 · Cited by 466
Immunological adjuvants: a role for liposomes
Gregoriadis, G. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90034-7 · Cited by 466
Improving protein therapeutics with sustained-release formulations
Putney, S. D., & Burke, P. A. (1998) · Nature Biotechnology · doi:10.1038/nbt0298-153 · Cited by 460
Vaccine design : the subunit and adjuvant approach
Powell, M. F., Newman, M. J., & Burdman, J. R. (1995) · Plenum Press eBooks · Cited by 451
Biodegradable Microspheres in Drug Delivery
Okada, H., & Toguchi, H. (1995) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v12.i1.10 · Cited by 397
Broide, D., Schwarze, J., Tighe, H., Gifford, T., Nguyen, M.-D., Malek, S., Van Uden, J., Martin-Orozco, E., Gelfand, E. W., & Raz, E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.7054 · Cited by 389
Salazar-Mather, T. P., Orange, J. S., & Biron, C. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.1 · Cited by 375
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
Messina, J. P., Gilkeson, G. S., & Pisetsky, D. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.6.1759 · Cited by 371
Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R., & Gilley, R. M. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.2978-2986.1991 · Cited by 368
Dickinson, B. L., & Clements, J. D. (1995) · Infection and Immunity · doi:10.1128/iai.63.5.1617-1623.1995 · Cited by 350
Allison, A. C., & Byars, N. E. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90402-3 · Cited by 315
CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
Moldoveanu, Z., Love-Homan, L., Huang, W. Q., & Krieg, A. M. (1998) · Vaccine · doi:10.1016/s0264-410x(98)80122-9 · Cited by 310
CpG motifs as immune adjuvants
Klinman, D. M., Barnhart, K. M., & Conover, J. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00151-0 · Cited by 308
Saponins as vaccine adjuvants.
Kensil, C. R. (1996) · PubMed · Cited by 296
Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2
Agrawal, B., Krantz, M. J., Reddish, M. A., & Longenecker, B. M. (1998) · Nature Medicine · doi:10.1038/nm0198-043 · Cited by 294
(1998) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49891998000900018 · Cited by 294
Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
Rappuoli, R., Pizza, M., Douce, G., & Dougan, G. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01523-6 · Cited by 284
Monophosphoryl lipid A as an adjuvant. Past experiences and new directions.
Ulrich, J. T., & Myers, K. R. (1995) · PubMed · Cited by 278
Douce, G., Turcotte, C., Cropley, I., Roberts, M., Pizza, M., Domenghini, M., Rappuoli, R., & Dougan, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1644 · Cited by 278
Biodegradable microparticles as controlled release antigen delivery systems.
O’Hagan, D. T., Rahman, D., McGee, J. P., Jeffery, H., Davies, M. C., Williams, P. M., Davis, S. S., & Challacombe, S. (1991) · PubMed Central · Cited by 270
Self-citationMcCluskie, M. J., & Davis, H. L. (1998) · PubMed · Cited by 264
Skin immunization made possible by cholera toxin
Glenn, G. M., Rao, M., Matyas, G. R., & Alving, C. R. (1998) · Nature · doi:10.1038/36014 · Cited by 261
Protection Against Vaginal SIV Transmission with Microencapsulated Vaccine
Marx, P. A., Compans, R. W., Gettie, A., Staas, J. K., Gilley, R. M., Mulligan, M. J., Yamshchikov, G. V., Chen, D., & Eldridge, J. H. (1993) · Science · doi:10.1126/science.8493576 · Cited by 261
Action of Saponin on Biological Cell Membranes
GLAUERT, A. M., DINGLE, J. T., & LUCY, J. A. (1962) · Nature · doi:10.1038/196953a0 · Cited by 259
Giuliani, M. M., Del Giudice, G., Giannelli, V., Dougan, G., Douce, G., Rappuoli, R., & Pizza, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1123 · Cited by 258
Ando, S., Putnam, D., Pack, D. W., & Langer, R. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9801687 · Cited by 243
O'Hagan, D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00012-x · Cited by 243
Self-citationMcCluskie, M. J., & Davis, H. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4463 · Cited by 237
Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses
Hedley, M. L., Curley, J., & Urban, R. (1998) · Nature Medicine · doi:10.1038/nm0398-365 · Cited by 235
Monophosphoryl Lipid A as an Adjuvant: Past Experiences and New Directions
Ulrich, J. T., & Myers, K. R. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_21 · Cited by 222
A Compendium of Vaccine Adjuvants and Excipients
Vogel, F. R., & Powell, M. F. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_7 · Cited by 217
Livingston, P. O., Adluri, S., Helling, F., Yao, T.-J., Kensilt, C. R., Newman, M. J., & Marciani, D. (1994) · Vaccine · doi:10.1016/s0264-410x(94)80052-2 · Cited by 214
Di Tommaso, A., Saletti, G., Pizza, M., Rappuoli, R., Dougan, G., Abrignani, S., Douce, G., & De Magistris, M. T. (1996) · Infection and Immunity · doi:10.1128/iai.64.3.974-979.1996 · Cited by 207
Straus, S. E., Savarese, B., Krause, P. R., Kost, R. G., Meier, J. L., Corey, L., Barnum, G., Burke, R. L., Sekulovich, R., Adair, S. F., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92581-x · Cited by 204
Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat
Hussain, N., Jani, P. U., & Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012153011884 · Cited by 191
ISCOMs and other saponin based adjuvants
Barr, I. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00013-1 · Cited by 189
Soltysik, S., Wu, J.-Y., Recchia, J., Wheeler, D. A., Newman, M. J., Coughlin, R. T., & Kensil, C. R. (1995) · Vaccine · doi:10.1016/0264-410x(95)00077-e · Cited by 188
Lectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers
Chen, H., Torchilin, V., & Langer, R. (1996) · Pharmaceutical Research · doi:10.1023/a:1016030202104 · Cited by 186
Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection
Dupuis, M., Murphy, T. J., Higgins, D., Ugozzoli, M., van Nest, G., Ott, G., & McDonald, D. M. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1283 · Cited by 185
Maloy, K. J., Donachie, A. M., O’Hagan, D. T., & Mowat, A. M. (1994) · PubMed Central · Cited by 183
Self-citationÅgren, L. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)88001-7 · Cited by 180
A Recombinant Glycoprotein Vaccine for Herpes Simplex Type 2: Safety and Efficacy
Langenberg, A. G. M., Burke, R. L., Adair, S. F., Sekulovich, R., Tigges, M., Dekker, C. L., & Corey, L. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-12-199506150-00001 · Cited by 177
Ghiara, P., Rossi, M., Marchetti, M., Di Tommaso, A., Vindigni, C., Ciampolini, F., Covacci, A., Telford, J. L., De Magistris, M. T., Pizza, M., et al. (1997) · Infection and Immunity · doi:10.1128/iai.65.12.4996-5002.1997 · Cited by 177
O'Hagan, D. T., Jeffery, H., & Davis, S. S. (1993) · Vaccine · doi:10.1016/0264-410x(93)90387-d · Cited by 175
Self-citationMarchetti, M., Rossi, M., Giannelli, V., Giuliani, M. M., Pizza, M., Censini, S., Covacci, A., Massari, P., Pagliaccia, C., & Manetti, R. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00153-9 · Cited by 170
Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin
Douce, G., Fontana, M., Pizza, M., Rappuoli, R., & Dougan, G. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2821-2828.1997 · Cited by 167
Challacombe, S., Rahman, D., Jeffery, H., Davis, S. S., & O’Hagan, D. T. (1992) · PubMed Central · Cited by 164
Self-citationSun, S., Kishimoto, H., & Sprent, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1145 · Cited by 158
Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system
Thoelen, S., Damme, P. V., Matheï, C., Leroux-Roels, G. G., Desombere, I., Safary, A., Vandepapelière, P., Slaoui, M., & Meheus, A. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00254-5 · Cited by 156
QS-21: a water-soluble triterpene glycoside adjuvant
Kensil, C. R., & Kammer, R. B. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.9.1475 · Cited by 152
Controlled release microparticles for vaccine development
O’Hagan, D. T., Jeffery, H., Roberts, M. J. J., McGee, J. P., & Davis, S. S. (1991) · Vaccine · doi:10.1016/0264-410x(91)90295-h · Cited by 149
Self-citationOtt, G., Barchfeld, G. L., & Nest, G. V. (1995) · Vaccine · doi:10.1016/0264-410x(95)00089-j · Cited by 147
A protein particle vaccine containing multiple malaria epitopes
Gilbert, S. C., Plebanski, M., Harris, S. J., Allsopp, C. E. M., Thomas, R., Layton, G. T., & Hill, A. V. S. (1997) · Nature Biotechnology · doi:10.1038/nbt1197-1280 · Cited by 147
Sasaki, S., Sumino, K., Hamajima, K., Fukushima, J., Ishii, N., Kawamoto, S., Mohri, H., Kensil, C. R., & Okuda, K. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.4931-4939.1998 · Cited by 147
Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo
Foster, N. M. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00222-3 · Cited by 146
Microparticles and polymers for the mucosal delivery of vaccines
O’Hagan, D. T. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00045-3 · Cited by 143
Self-citationImmunogenicity and protectivity of a new liposomal hepatitis A vaccine
Ambrosch, F. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00015-7 · Cited by 140
Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity
Nixon, D. F., Hioe, C. E., Chen, P., Bian, Z., Kuebler, P., Li, M.-L., Qiu, H., Li, X.-M., Singh, M., Richardson, J. L., et al. (1996) · Vaccine · doi:10.1016/s0264-410x(96)00099-0 · Cited by 133
Self-citationAlving, C. R. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(92)90004-t · Cited by 112
Rimmelzwaan, G. F., van Beek, R., van Amerongen, G., Claas, E. C., L√∂vgren-Bengtsson, K., Osterhaus, A. D. M. E., & Baars, M. M. J. W. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-4-757 · Cited by 108
Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine
Payne, L. G., Jenkins, S. A., Woods, A. L., Grund, E. M., Geribo, W. E., Loebelenz, J. R., Andrianov, A. K., & Roberts, B. E. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00149-7 · Cited by 107
TODA, S., Ishii, N., Okada, E., Kusakabe, K., Arai, H., Hamajima, K., Gorai, I., Nishioka, K., & Okuda, K. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00307.x · Cited by 106
Relyveld, E. H. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00288-0 · Cited by 106
Optimism over vaccines administered via mucosal surfaces
Levine, M. M., & Dougan, G. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79439-3 · Cited by 103
Traquina, P., Morandi, M., Contorni, M., & Nest, G. V. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1168 · Cited by 100
Ågren, L., Ekman, L., Löwenadler, B., Nedrud, J. G., & Lycke, N. Y. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2432 · Cited by 98
Challacombe, S., Rahman, D., & O’Hagan, D. T. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00159-4 · Cited by 96
Self-citationTargeting immune response induction with cochleate and liposome-based vaccines
Gould-Fogerite, S. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00014-3 · Cited by 94
Klavinskis, L. S., Bergmeier, L. A., Gao, L., Mitchell, E. A., Ward, R. G., Layton, G. T., Brookes, R. H., Meyers, N., & Lehner, T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2521 · Cited by 93
Shahin, R. D., Leef, M. F., Eldridge, J. H., Hudson, M. E., & Gilley, R. M. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1195-1200.1995 · Cited by 93
Goletz, T. J., Klimpel, K. R., Arora, N., Leppla, S. H., Keith, J. M., & Berzofsky, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12059 · Cited by 89
Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins
Giannasca, P. J., Boden, J. A., & Monath, T. P. C. (1997) · Infection and Immunity · doi:10.1128/iai.65.10.4288-4298.1997 · Cited by 89
Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles
O’Hagan, D. T., Ott, G. S., & Nest, G. V. (1997) · Molecular Medicine Today · doi:10.1016/s1357-4310(96)10058-7 · Cited by 88
Self-citationPolymerized liposomes as potential oral vaccine carriers: Stability and bioavailability
Chen, H., Torchilin, V. P., & Langer, R. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(96)01459-9 · Cited by 76
Jones, D. H., McBride, B. W., Thornton, C., O’Hagan, D. T., Robinson, A., & Farrar, G. H. (1996) · Infection and Immunity · doi:10.1128/iai.64.2.489-494.1996 · Cited by 75
Self-citationMF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice
Higgins, D. A., Carlson, J. R., & Nest, G. V. (1996) · Vaccine · doi:10.1016/0264-410x(95)00240-2 · Cited by 74
Tseng, J., Komisar, J. L., Trout, R. N., Hunt, R. E., Chen, J. Y., Johnson, A. J., Pitt, M. L. M., & Ruble, D. L. (1995) · Infection and Immunity · doi:10.1128/iai.63.8.2880-2885.1995 · Cited by 74
Development of adjuvant-active nonionic block copolymers
Newman, M. J. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00011-8 · Cited by 73
Use of cellular and cytokine adjuvants in the immunotherapy of cancer
Salgaller, M. L., & Lodge, P. A. (1998) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199806)68:2<122::aid-jso10>3.0.co;2-4 · Cited by 70
UGOZZOLI, O’HAGAN, & OTT (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00441.x · Cited by 69
Whittum‐Hudson, J. A., An, L., Saltzman, W. M., Prendergast, R. A., & MacDonald, A. (1996) · Nature Medicine · doi:10.1038/nm1096-1116 · Cited by 67
Allaoui-Attarki, K., Pecquet, S., Fattal, E., Trollé, S., Chachaty, É., Couvreur, P., & Andremont, A. (1997) · Infection and Immunity · doi:10.1128/iai.65.3.853-857.1997 · Cited by 64
Granoff, D. M., McHugh, Y. E., Raff, H. V., Mokatrin, A., & Nest, G. A. V. (1997) · Infection and Immunity · doi:10.1128/iai.65.5.1710-1715.1997 · Cited by 62
Martin, S. J., Vyakarnam, A., CHEINGSONG-POPOV, R., Callow, D., Jones, K. L., Senior, J. M., Adams, S. E., Kingsman, A. J., Matear, P. M., & Gotch, F. (1993) · PubMed · Cited by 60
Cataldo, D. M., & Nest, G. V. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00115-1 · Cited by 54
Gustafson, G. L., & Rhodes, M. J. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80058-s · Cited by 53
Giannelli, V., Fontana, M. R., Giuliani, M. M., Guangcai, D., Rappuoli, R., & Pizza, M. (1997) · Infection and Immunity · doi:10.1128/iai.65.1.331-334.1997 · Cited by 52
Ling, I. T., Ogun, S. A., Momin, P., Richards, R. L., Garçon, N., Cohen, J., Ballou, W. R., & Holder, A. A. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00076-5 · Cited by 48
Steroid Hormones and the T-cell Cytokine Profile
Wilckens, T. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01273-0 · Cited by 24
(1996) · Europe PMC (PubMed Central)
Cited by
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Fujii, S.-I., Shimizu, K., Smith, C., Bonifaz, L., & Steinman, R. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030324 · Cited by 711
New horizons in adjuvants for vaccine development
Reed, S. G., Bertholet, S., Coler, R. N., & Friede, M. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.09.006 · Cited by 618
New horizons in adjuvants for vaccine development
Reed, S. G., Tomai, M., & Gale, M. J. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.08.008 · Cited by 554
Jäger, E., Gnjatic, S., Nagata, Y., Stockert, E., Jäger, D., Karbach, J., Neumann, A., Rieckenberg, J., Chen, Y.-T., Ritter, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220413497 · Cited by 426
Metadata
- Authors
- Singh, M., & O'Hagan, D.
- Venue
- Nature Biotechnology
- Published
- 1999-11
- Volume
- 17
- Issue
- 11
- Pages
- 1075-1081
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W1572881837
- Cited by
- 506
- References
- 116
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.